For the quarter ending 2026-03-31, HRGN has $1,798K in assets. $1,706K in debts. $419K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 419 | 1,352 | 1,319 | 786 |
| Accounts receivable | 16 | 16 | 3 | 5 |
| Inventory | 15 | 16 | 22 | 27 |
| Prepaid research and development | 18 | 18 | 53 | 53 |
| Prepaid expenses and other current assets | 405 | 427 | 230 | 246 |
| Total current assets | 873 | 1,829 | 1,627 | 1,117 |
| Total property, plant and equipment | - | 1,487 | - | - |
| Less accumulated depreciation | - | 1,481 | - | - |
| Property, plant and equipment, net | 5 | 6 | 7 | 8 |
| Right-of-use assets, net | 168 | 195 | 221 | 245 |
| Long-term prepaid contracts | 752 | 647 | 691 | 767 |
| Total assets | 1,798 | 2,677 | 2,546 | 2,137 |
| Accounts payable | 239 | 454 | 313 | 352 |
| Accrued and other current liabilities | 839 | 532 | 327 | 563 |
| Deferred revenue | 340 | 252 | 128 | 149 |
| Insurance premium financing payable | 115 | 183 | 0 | 63 |
| Operating lease liability | 118 | 113 | 108 | 104 |
| Total current liabilities | 1,651 | 1,534 | 876 | 1,231 |
| Operating lease liability, net of current portion | 55 | 86 | 116 | 145 |
| Total liabilities | 1,706 | 1,620 | 992 | 1,376 |
| Common stock, par value 0.01 per share, 60,000,000 shares authorized 17,580,744 shares issued and outstanding at each of march 31, 2026 and december 31, 2025 | 176 | 176 | 172 | 159 |
| Additional paid-in capital | 108,082 | 107,450 | 106,261 | 103,779 |
| Accumulated deficit | -108,158 | -106,557 | -104,870 | -103,170 |
| Accumulated other comprehensive loss | -8 | -12 | -9 | -7 |
| Total stockholders equity | 92 | 1,057 | 1,554 | 761 |
| Total liabilities and stockholders equity | 1,798 | 2,677 | 2,546 | 2,137 |
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. (HRGN)